Evidence map›Paper›PMID 41861825›Full record

ArticleCell stem cell2026

Species-specific chromatin architecture and neurogenesis mediated by a human enhancer.

Federica Mosti, Jing Liu, Katie Lam, Noah R Dillon, Samantha Skavicus, Victoria A Kapps, Ketrin Gjoni, Chia-Fang Lee, Emily N Glidewell, Nicholas S Heaton and 2 more

Abstract read
In one paragraph

Article in Cell stem cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Federica MostiDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA; Department of Neurobiology, Duke University School of Medicine, Durham, NC 27710, USA.
Jing LiuDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Katie LamDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Noah R DillonDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Samantha SkavicusDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Victoria A KappsDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Ketrin GjoniGladstone Institute of Data Science and Biotechnology, San Francisco, CA 94158, USA; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA 94158, USA.
Chia-Fang LeeDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA; Department of Neurobiology, Duke University School of Medicine, Durham, NC 27710, USA.
Emily N GlidewellDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Nicholas S HeatonDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Duke Center for Virology, Duke University School of Medicine, Durham, NC 27710, USA.
Katherine S PollardGladstone Institute of Data Science and Biotechnology, San Francisco, CA 94158, USA; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA 94158, USA; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.
Debra L SilverDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA; Department of Neurobiology, Duke University School of Medicine, Durham, NC 27710, USA; Department of Cell Biology, Duke University School of Medicine, Durham, NC 27710, USA; Duke Institute for Brain Sciences and Duke Regeneration Center, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: debra.silver@duke.edu.

Funding

Mechanisms of neural progenitor division in the developing brainR01NS083897 · NINDS · DUKE UNIVERSITY · PI SILVER, DEBRA · 2013 to 2023
$3.4M
Investigating sex differences in DDX3X mouse modelsR01NS120667 · NINDS · DUKE UNIVERSITY · PI SILVER, DEBRA L. · 2021 to 2025
$3.4M
Roles for uniquely human enhancers in brain development and WNT signalingR01MH132089 · NIMH · DUKE UNIVERSITY · PI Debra L. Silver · 2023 to 2026
$2.6M
Distal mRNA localization and translation in neural stem cells of the developing brainR37NS110388 · NINDS · DUKE UNIVERSITY · PI Debra L. Silver · 2024 to 2026
$2.2M
NIMH NIH HHS R01 MH132089NINDS NIH HHS R01 NS083897NINDS NIH HHS R01 NS120667NINDS NIH HHS R37 NS110388
6 · The paper itself

Abstract

Genomic modifications underlie the evolution of human brain features, including a larger neocortex. Human accelerated regions (HARs) are highly conserved loci containing human-specific variants, with ∼50% identified as neurodevelopmental enhancers. However, the neurodevelopmental functions of HARs and their mechanisms of gene regulation are largely unknown. We show that human (Homo sapiens [Hs]) HAR1984 promotes neurogenesis by influencing species-specific transcription and chromatin interactions. Hs-HAR1984 knockin chimpanzee (Pan troglodytes [Pt]) cortical organoids contain more progenitors and neurons, whereas Pt-HAR1984 knockin human cortical organoids exhibit the opposite phenotype. Hs-HAR1984 knockin mice have increased neurogenesis and a thicker cortex with focal folds. HAR1984 exhibits chromatin looping with its target genes, ETV5 and TRA2B, in human fetal brains, which is notably reduced in chimpanzee, macaque, and mouse neural cells. We show that human-specific HAR1984 promotes these interactions and that human-specific ETS variant transcription factor 5 (ETV5) binding auto-regulates enhancer activity. Our study demonstrates molecular mechanisms underlying human-specific neurodevelopment, linking HARs to chromatin architecture, cortical fate, and expansion.

Indexed as

ChromatinEnhancer Elements, GeneticNeurogenesisAnimalsHumansMiceNeurodevelopmentNeuronsPan troglodytesSpecies SpecificityTranscription FactorsChromatinTranscription Factorschimpanzeechromatin loopscortical developmentcortical organoidsenhancerevolutiongene regulationHARshumanneurogenesis

Identifiers

PMID41861825
PMCPMC13142994

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.